Promega Corporation
its NanoLuc luciferase platform continues to anchor new research, including a July 2025 study using NanoBiT/NanoBRET tags at endogenous gene loci for cancer protein-protein-interaction reporter cell lines, and a January 2026 paper engineering GFP-NanoLuc BRET fusion substrates for protease-activity detection.
- Country
- United States
bioluminescence
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| marine-biotech | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bioluminescence & marine fluorescent proteins | marine-biotech | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.